What is Alzheimer's disease? Signs and symptoms to know
Alzheimer's is the most common form of dementia and the seventh-leading cause of death of adults in the U.S.
Search fresh public links, source activity, and ready-to-use post angles for Alzheimer's.
Fresh curated links around Alzheimer's are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Alzheimer's is the most common form of dementia and the seventh-leading cause of death of adults in the U.S.
The discovery of a new seed of the amyloid beta protein could lead to early-stage therapy for neurodegenerative disease, according to researchers.
Alzheimer's just gave up another one of its secrets.ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.
A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced infl...
New Delhi, Aug 25: A novel smartphone-enabled platform employing afluorescence-responsive tiny molecule as a probe offers a simple, cost-effective, and accessible approach for the...
An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau
Bill Ritter spoke with doctors at Columbia about Alzheimer's disease and their groundbreaking research.
Researchers say the oral drug LM11A-31 slowed the decline of brain-network function in a small trial, pointing to a potential broader strategy for treating Alzheimer’s.
A blood test may predict if apparently healthy older adults are likely to develop Alzheimer’s symptoms in the next five or 10 years, researchers reported.
A blood test for Alzheimer's disease biomarkers helped improve diagnostic accuracy among specialists and primary care physicians in a real-world study.In a head-to-head comparison...
Hyperphosphorylated tau invades mitochondria and triggers reverse electron transport, opening a novel target for treating Alzheimer's disease and tauopathies.
[The content of this article has been produced by our advertising partner.] As populations age and social stressors increase worldwide, cognitive health has become a pressing publi...
New blood tests are beginning to reshape Alzheimer’s diagnostics by detecting molecular changes linked to the disease years earlier than symptom onset. Compared with brain imaging...
An experimental drug might help slow early Alzheimer's disease in a markedly different way than today's treatments — by lowering levels of a brain protein called tau, researchers r...
Researchers identified mitochondrial plaques, an intracellular form of pathology that forms early in Alzheimer's disease and offers a new target for treatment.
Measuring Predictive Age Difference (PAD), the team found that Alzheimer’s disease and mild cognitive impairment showed the highest accelerated brain aging, followed by psychiatric...
Scientists have identified a possible tipping point that helps determine whether Alzheimer’s-related brain changes lead to dementia. The key may lie in how the brain’s immune cells...
An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau.
Key Takeaways
If you’ve ever forgotten why you walked into a room and felt a flicker of worry, you’re not alone. About 6.9 million Americans are living with Alzheimer’s disease, and one in nine...
A new ETH Zurich compound called Compound 10 blocks a misbehaving enzyme linked to Alzheimer's, slowing nerve cell death in mice. The post A Newly Discovered Alzheimer’s Trigger Co...
by Asgeir Kobro-Flatmoen, Jagir R. Hussan, Peter J. Hunter, Stig W. Omholt The entorhinal cortex (EC) plays a crucial role in memory functions. Long before the clinical symptoms o...
A 2026 Nature Neuroscience study found structural brain changes visible by MRI at least 7 years before Alzheimer's amyloid plaques appear on PET The post Brain Scans Reveal a Hidde...
Brain changes associated with Alzheimer’s may begin at least seven years before amyloid plaques become detectable with current PET scans. Researchers uncovered the signal by tracki...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.